These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25660152)
1. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights. Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152 [TBL] [Abstract][Full Text] [Related]
2. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres. Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357 [TBL] [Abstract][Full Text] [Related]
3. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance. Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016 [TBL] [Abstract][Full Text] [Related]
6. Treatment of in-stent restenosis with sirolimus-eluting magnesium bioresorbable scaffolds: optical coherence tomography insights. Cuesta J; Rivero F; Bastante T; Antuña P; Jiménez-Méndez C; García-Guimaraes M; Alfonso F Coron Artery Dis; 2022 Aug; 33(5):362-367. PubMed ID: 35170552 [TBL] [Abstract][Full Text] [Related]
7. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography. Grasso C; Attizzani GF; Patané M; Ohno Y; Capodanno D; Tamburino C Int J Cardiol; 2013 Oct; 168(4):4490-1. PubMed ID: 23890924 [No Abstract] [Full Text] [Related]
8. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654 [No Abstract] [Full Text] [Related]
9. Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience. Moscarella E; Varricchio A; Stabile E; Latib A; Ielasi A; Tespili M; Cortese B; Calabrò P; Granata F; Panoulas VF; Franzone A; Trimarco B; Bonzani G; Esposito G; Colombo A Int J Cardiol; 2015 Nov; 199():366-72. PubMed ID: 26241643 [TBL] [Abstract][Full Text] [Related]
10. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Alfonso F; Dutary J; Paulo M; Gonzalo N; Pérez-Vizcayno MJ; Jiménez-Quevedo P; Escaned J; Bañuelos C; Hernández R; Macaya C Heart; 2012 Aug; 98(16):1213-20. PubMed ID: 22826559 [TBL] [Abstract][Full Text] [Related]
11. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. Diletti R; Karanasos A; Muramatsu T; Nakatani S; Van Mieghem NM; Onuma Y; Nauta ST; Ishibashi Y; Lenzen MJ; Ligthart J; Schultz C; Regar E; de Jaegere PP; Serruys PW; Zijlstra F; van Geuns RJ Eur Heart J; 2014 Mar; 35(12):777-86. PubMed ID: 24394380 [TBL] [Abstract][Full Text] [Related]
12. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience. Karanasos A; Van Mieghem N; van Ditzhuijzen N; Felix C; Daemen J; Autar A; Onuma Y; Kurata M; Diletti R; Valgimigli M; Kauer F; van Beusekom H; de Jaegere P; Zijlstra F; van Geuns RJ; Regar E Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969547 [TBL] [Abstract][Full Text] [Related]